Comments on the FDA draft guidance on adaptive designs.
Statistics Collaborative, Inc., Washington, DC, USA. janet@statcollab.com
Janet
J
Wittes
D002986:Clinical Trials as Topic / Q000379:methods* / Q000706:statistics & numerical data; D017326:Clinical Trials, Phase III as Topic; D003627:Data Interpretation, Statistical; D017277:Drug Approval / Q000379:methods*; D017408:Guidelines as Topic; D006801:Humans; D015233:Models, Statistical; D015203:Reproducibility of Results; D012107:Research Design; D016896:Treatment Outcome; D014481:United States